|
Publications
- Goldenberg RL, Klebanoff M, Carey JC, Ernest J, Heine RP,
MacPherson C, Leveno, KJ, Wapner RJ, Varner JM, Moawad A,
Dombrowski MP, O'Sullivan MJ, VanDorsten PJ, Langer O, Roberts JM,
McNellis D for the NICHD MFMU Network.
Vaginal fetal fibronectin measurements from 8 to 22 weeks' gestation
and subsequent spontaneous preterm birth.
American Journal of Obstetrics & Gynecology,
183(2): 469-75, 2000.
- Goldenberg RL, Klebanoff M, Carey JC, MacPherson C, for the
NICHD MFMU Network. Metronitazole treatment of women with a
positive fetal fibronectin test result.
American Journal of Obstetrics & Gynecology,
185(2): 485-486, 2001.
- Klebanoff MA, Hillier SL, Nugent RP, MacPherson CA, Hauth JC,
Ernest JM, Wapner RJ, Trout W, Moawad A, Leveno KJ, Miodovnik M
and the NICHD Maternal-Fetal Medicine Units Network. Is bacterial
vaginosis a stronger risk factor for preterm birth when it is
diagnosed earlier in gestation? American Journal of Obstetrics
& Gynecology, 192:470-477, 2005.
Presentations
- Goldenberg RL, for the NICHD MFMU Network. Vaginal fetal
fibronectin levels at 8-22 weeks and subsequent spontaneous
preterm birth. Presented at the 20th Annual Meeting of the Society
for Maternal-Fetal Medicine, Miami, FL,
February 2000.
- Simhan H, for the NICHD MFMU Network. Bacterial vaginosis,
elevated pH, and second terimester pregnancy loss. Presented at
the 23rd Annual Meeting of the Society for Maternal Fetal Medicine,
San Francisco, CA, February 2003.
- Klebanoff M. Is bacterial vaginosis diagnosed early
in pregnancy a stronger risk factor for preterm birth than
bacterial vaginosis diagnosed later? Presented at the 17th
Annual Meeting of the Society for Pediatric and Perinatal
Epidemiology Research, Salt Lake City, June 2004.
|
